
Agustín Toll
Grup de recerca
- Melanoma: imatge, genètica i immunologia Accredited researcher (R3A)
Publicacions destacades
-
Mohs surgery: a long-term, nationwide prospective cohort to describe recurrence rate and risk factors (REGESMOHS, Spanish Registry of Mohs Surgery)
Autors:Referència: Journal Of The European Academy Of Dermatology And Venereology 2022. -
PATTERNS OF INCIDENTAL PERINEURAL INVASION AND PROGNOSIS IN CUTANEOUS SQUAMOUS CELL CARCINOMA: A MULTICENTER, RETROSPECTIVE COHORT STUDY
Autors:Referència: Journal Of The American Academy Of Dermatology 2021. -
Risk Factors and Rate of Recurrence after Mohs Surgery in Basal Cell and Squamous Cell Carcinomas: A Nationwide Prospective Cohort (REGESMOHS, Spanish Registry of Mohs Surgery)
Autors:Referència: Acta Dermato-Venereologica 2021. -
Erythematous papules on the penis as first manifestation of metastatic prostate adenocarcinoma
Autors:Referència: Dermatology Online Journal 2021. -
Estimated Effect of COVID-19 Lockdown on Skin Tumor Size and Survival: An Exponential Growth Model
Autors:Referència: Actas Dermo-Sifiliograficas 2020. -
Molecular characterisation of oncogenic urothelial mosaic mutations in patients with extensive keratinocytic epidermal naevi
Autors:Referència: Journal Of Medical Genetics 2020. -
Identification of differentially expressed genes in actinic keratosis samples treated with ingenol mebutate gel
Autors:Referència: Plos One 2020. -
Postoperative radiotherapy provides better local control and long-term outcome in selective cases of cutaneous squamous cell carcinoma with perineural invasion.
Autors:Referència: Journal Of The European Academy Of Dermatology And Venereology 2020. -
State of the art of Mohs surgery for rare cutaneous tumors in the Spanish Registry of Mohs Surgery (REGESMOHS)
Autors:Referència: International Journal Of Dermatology 2020. -
Transcriptome and cytogenetic profiling analysis of matched in situ/invasive cutaneous squamous cell carcinomas from immunocompetent patients
Autors:Referència: Genes Chromosomes & Cancer 2019.
Projectes destacats
-
Development and Validation of a Gene Expression assay to Predict the Risk of Recurrence Disease in Cutaneous Squamous Cell Carcinoma
Durada: 31/08/2021 - 23/03/2022 -
Estudio de fase 2 de REGN2810, un anticuerpo monoclonal totalmente humano contra la proteína de muerte celular programada-1 (PD-1), en pacientes con carcinoma epidermoide cutáneo avanzado
Durada: 05/11/2019 -
Red de cáncer cutáneo no melanoma en Cataluña
Investigador/a principal: Agustín Toll, Agustín Toll AbellóDurada: 13/03/2019 -
Regulación epigenética de la función inflamatoria del componente epitelial en la progresión metastática del carcinoma escamoso cutáneo (CEC)
Investigador/a principal: María Inmaculada Hernández MuñozDurada: 01/01/2016 - 31/12/2018 -
Estudio del perfil genómico y de expresión en carcinomas escamosos cutáneos invasivos e intraepiteliales
Investigador/a principal: Agustin Toll AbelloDurada: 01/01/2011 - 31/12/2013